HMGCR and Alzheimer disease: In the present study, we demonstrated that our AD model was useful in the chemical screening of previously reported Aβ inhibitors, including γ-secretase inhibitors and HMG-CoA reductase inhibitors27, 28, 29, 30, 31, 34, 35, 36.